Dr. Dena Grayson
Dr. Dena Grayson

@DrDenaGrayson

6 Tweets 32 reads Apr 17, 2020
?BREAKING: preliminary data from an ongoing clinical study of #remdesivir showed that in 113 patients with severe #COVID19:
▶️Fever/symptoms rapidly improved
▶️Most discharged within 6 days
▶️2 died (1.8%), much less than expected for severe #COVID19
statnews.com
#Remdesivir is being studied in 2 clinical trials:
1⃣severe #COVID19 study of 2,400 patients from 152 sites all over the world
2⃣moderate #COVID19 study of 1,600 patients in 169 sites.
Results for the first 400 patients in the "severe" study are expected later this month.?
I spent nearly a decade developing the closely related #galidesivir (BCX4430, we published in @nature) that is also being tested in #COVID19 patients.
These drugs decrease viral replication by blocking the virus' ability to make new RNA.
Another closely related drug #favipiravir that works the same way as #remdesivir and #galidesivir showed activity in a study of #COVID19 patients in #China.
There's a decent chance that 1 or more these drugs will prove effective against #coronavirus.??
One patient with a fever of 104 and shortness of breath says after 1 dose of #remdesivir, “My fever dropped almost immediately & I started to feel better."
By his 2nd dose, he was being weaned off oxygen. After 2 more doses he was discharged.
“Remdesivir was a miracle.”
For months, I've publicly shared my support for these drugs, because of how they work. This is *only 1* patient and does NOT prove anything. We need to see the full results of the clinical study of #remdesivir, but this preliminary report is encouraging.??
statnews.com

Loading suggestions...